A Novel Disease Gene for Brugada Syndrome: Sarcolemmal Membrane–Associated Protein Gene Mutations Impair Intracellular Trafficking of hNav1.5

Background— Mutations in genes including SCN5A encoding the &agr;-subunit of the cardiac sodium channel (hNav1.5) cause Brugada syndrome via altered function of cardiac ion channels, but more than two-thirds of Brugada syndrome remains pathogenetically elusive. T-tubules and sarcoplasmic reticulum are essential in excitation of cardiomyocytes, and sarcolemmal membrane-associated protein (SLMAP) is a protein of unknown function localizing at T-tubules and sarcoplasmic reticulum. Methods and Results— We analyzed 190 unrelated Brugada syndrome patients for mutations in SLMAP. Two missense mutations, Val269Ile and Glu710Ala, were found in heterozygous state in 2 patients but were not found in healthy individuals. Membrane surface expression of hNav1.5 in the transfected cells was affected by the mutations, and silencing of mutant SLMAP by small interfering RNA rescued the surface expression of hNav1.5. Whole-cell patch-clamp recordings of hNav1.5-expressing cells transfected with mutant SLMAP confirmed the reduced hNav1.5 current. Conclusions— The mutations in SLMAP may cause Brugada syndrome via modulating the intracellular trafficking of hNav1.5 channel.

[1]  A. Leenhardt,et al.  MOG1: A New Susceptibility Gene for Brugada Syndrome , 2011, Circulation. Cardiovascular genetics.

[2]  Hugues Abriel,et al.  Cardiac sodium channel Na(v)1.5 and interacting proteins: Physiology and pathophysiology. , 2010, Journal of molecular and cellular cardiology.

[3]  N. Borgese,et al.  Targeting pathways of C-tail-anchored proteins. , 2011, Biochimica et biophysica acta.

[4]  Wataru Shimizu,et al.  Brugada syndrome: report of the second consensus conference. , 2005, Heart rhythm.

[5]  H. Ding,et al.  Increased Expression of the Tail-Anchored Membrane Protein SLMAP in Adipose Tissue from Type 2 Tally Ho Diabetic Mice , 2011, Experimental diabetes research.

[6]  C Antzelevitch,et al.  The Brugada Syndrome , 1998, Journal of cardiovascular electrophysiology.

[7]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[8]  G. Breithardt,et al.  Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome , 2005, Circulation.

[9]  M. Salih,et al.  Hydrophobic profiles of the tail anchors in SLMAP dictate subcellular targeting , 2009, BMC Cell Biology.

[10]  C. Antzelevitch,et al.  A Mutation in the β3 Subunit of the Cardiac Sodium Channel Associated With Brugada ECG Phenotype , 2009, Circulation. Cardiovascular genetics.

[11]  R. Guzzo,et al.  A novel isoform of sarcolemmal membrane-associated protein (SLMAP) is a component of the microtubule organizing centre , 2004, Journal of Cell Science.

[12]  W. Staines,et al.  Molecular Cloning, Expression, and Chromosomal Assignment of Sarcolemmal-associated Proteins , 1997, The Journal of Biological Chemistry.

[13]  P. Schwartz,et al.  Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. , 2010, Heart rhythm.

[14]  M. Ackerman,et al.  A ZASP Missense Mutation, S196L, Leads to Cytoskeletal and Electrical Abnormalities in a Mouse Model of Cardiomyopathy , 2010, Circulation. Arrhythmia and electrophysiology.

[15]  J. Towbin,et al.  An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. , 2010, Heart rhythm.

[16]  Carlo Napolitano,et al.  Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[18]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[19]  Charles Antzelevitch.  Brugada syndrome. , 2006, Pacing and clinical electrophysiology : PACE.

[20]  J L Rey,et al.  Prevalence of the brugada syndrome in an apparently healthy population. , 2000, The American journal of cardiology.

[21]  D. Lancet,et al.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. , 2001, American journal of human genetics.

[22]  Michael J Ackerman,et al.  Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. , 2003, Mayo Clinic proceedings.

[23]  K. Ueda,et al.  Role of HCN4 channel in preventing ventricular arrhythmia , 2009, Journal of Human Genetics.

[24]  T. Jespersen,et al.  Inherited Cardiac Diseases Caused by Mutations in the Nav1.5 Sodium Channel , 2010, Journal of cardiovascular electrophysiology.

[25]  Martin Borggrefe,et al.  Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. , 2010, Heart rhythm.

[26]  P. C. Viswanathan,et al.  Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias , 2007, Circulation.

[27]  P. Schwartz,et al.  Spectrum and Prevalence of Mutations Involving Brs1-through Brs12-susceptibility Genes in a Cohort of Unrelated Patients Referred for Brugada Syndrome Genetic Testing Implications for Genetic Testing , 2022 .

[28]  Arthur A M Wilde,et al.  Cardiac ion channels in health and disease. , 2010, Heart rhythm.

[29]  P. Schwartz,et al.  Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. , 2011, Heart rhythm.

[30]  H. Wichmann,et al.  Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. , 2008, The Journal of clinical investigation.

[31]  T. Iwasaka,et al.  Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. , 2001, Journal of the American College of Cardiology.

[32]  Michael Christiansen,et al.  The genetic basis of Brugada syndrome: A mutation update , 2009, Human mutation.

[33]  C. Orchard,et al.  T‐Tubule Function in Mammalian Cardiac Myocytes , 2003, Circulation research.

[34]  S. Priori,et al.  Natural History of Brugada Syndrome: Insights for Risk Stratification and Management , 2002, Circulation.

[35]  G. Breithardt,et al.  Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: Different incidences in familial and sporadic disease , 2003, Human mutation.

[36]  E. Behr,et al.  The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. , 2008, The Journal of clinical investigation.